Rachel Freedman, MD

Medical Oncology

Rachel Freedman, MD

View full profile

Related Videos

2026 ASCO Breast Cancer Highlights: Food Access, Poverty, and MBC Video

2026 ASCO Breast Cancer Highlights: Food Access, Poverty, and MBC

Harold Burstein, MD, PhD, and Rachel Freedman, MD, MPH discuss the results of a new study looking at the impact of food access and poverty on patients with metastatic breast cancer. They also discuss the new Dana-Farber food pantry and ...

Rachel Freedman, MD discusses phase 2 ATOP study Video

Rachel Freedman, MD discusses phase 2 ATOP study

Dana-Farber Cancer Institute's Rachel Freedman, MD, presents results from the phase 2 ATOP study showing older patients with HER2+ breast cancer receiving adjuvant T-DM1 had a favorable 5-year survival with manageable toxicity. ATOP is ...